Form 4: Clover Health Officer Sells Shares for Tax Withholding

Clover Health Investments Corp. Chief Legal Officer Karen Soares sold shares to cover tax obligations related to RSU vesting, a non-discretionary transaction.

Summary

• Karen Soares, Chief Legal Officer at Clover Health Investments, Corp., reported a transaction on June 15, 2026.
• The transaction involved the sale of 4,681 shares of Class A Common Stock.
• These sales were executed to cover tax withholding obligations upon the vesting of restricted stock units (RSUs).
• The sales were conducted under a 'sell to cover' arrangement mandated by the company's equity incentive plans, meaning they were not discretionary trades.
• The shares were sold at a weighted average price of $4.61, with individual sales ranging from $4.61 to $4.64.
• Following these transactions, Karen Soares beneficially owns 1,567,741 shares of Class A Common Stock, held directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it involves a sale of shares, the explanation clearly indicates it's a non-discretionary transaction to cover tax obligations, which is a standard practice.

Positives

• The transaction was a mandatory 'sell to cover' to satisfy tax obligations, indicating no discretionary selling by management.
• The reporting person continues to hold a significant number of shares (1,567,741) after the transaction.

Negatives

• A portion of the reporting person's equity was sold, reducing their direct shareholding.

Risks

• The filing does not explicitly mention any new risks. However, the sale of shares, even if for tax purposes, could be perceived negatively by the market if not clearly understood as non-discretionary.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it solely reports a past transaction.

Management Comments

• The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ('RSUs').
• These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The 'sell to cover' mechanism for RSU vesting is a common practice across the tech and healthcare industries to manage tax liabilities without requiring executives to use personal funds.

Stakeholder Impact

• Shareholders: The sale is non-discretionary and for tax purposes, so it should not be interpreted as a negative signal about the company's prospects. The reporting person retains a substantial number of shares.
• Employees: This transaction relates to executive compensation and tax management, with no direct impact on other employees.
• Management: The transaction fulfills tax obligations related to equity compensation for the Chief Legal Officer.

Next Steps

• No specific next steps are outlined in this filing beyond the completion of the reported transaction.

Key Dates

Keywords

Form 4, Insider Transaction, Clover Health, CLOV, Karen Soares, RSU Vesting, Tax Withholding, Sell to Cover, Common Stock, Beneficial Ownership